1,872
Views
4
CrossRef citations to date
0
Altmetric
Article

Simple Vision Function Tests that Distinguish Eyes with Early to Intermediate Age-related Macular Degeneration

, , , , , , , & show all
Pages 93-104 | Received 13 Nov 2019, Accepted 30 Jun 2020, Published online: 12 Aug 2020

References

  • Mitchell P, Smith W, Attebo K, Wang JJ. Prevalence of age-related maculopathy in Australia. The blue mountains eye study. Ophthalmol. 1995;102(10):1450–1460. doi:10.1016/S0161-6420(95)30846-9.
  • Vingerling JR, Dielemans I, Hofman A, et al. The prevalence of age-related maculopathy in the Rotterdam Study. Ophthalmol. 1995;102(2):205–210. doi:10.1016/S0161-6420(95)31034-2.
  • Colijn JM, Buitendijk GHS, Prokofyeva E, et al. Prevalence of age-related macular degeneration in Europe. The past and the future. Ophthalmol. 2017;124(12):1753–1763. doi:10.1016/j.ophtha.2017.05.035.
  • United States Census Bureau. An aging nation: the older population in the United States: population estimates and projections ( Released May, 2014). Accessed 15 June 20 https://www.census.gov/prod/2014pubs/p25-1140.pdf
  • National Eye Institute (NEI). Age-related macular degeneration (AMD) tables: projections for AMD (2010-2030-2050). Accessed 15June20 https://www.nei.nih.gov/learn-about-eye-health/resources-for-health-educators/eye-health-data-and-statistics/age-related-macular-degeneration-amd-data-and-statistics/age-related-macular-degeneration-amd-tables
  • Brown DM, Michels M, Kaiser PK, et al. Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: two-year results of the ANCHOR study. Ophthalmol. 2009;116(1):57–65. doi:10.1016/j.ophtha.2008.10.018.
  • Rofagha S, Bhisitkul RB, Boyer DS, Sadda SR, Zhang K. SEVEN-UP study group. Seven-year outcomes in ranibizumab-treated patients in ANCHOR, MARINA, and HORIZON: a multicenter cohort study (SEVEN-UP). Ophthalmol. 2013;120(11):2292–2299. doi:10.1016/j.ophtha.2013.03.046.
  • Finger RP, Wickremasinghe SS, Baird PN, Guymer RH. Predictors of anti-VEGF treatment response in neovascular age-related macular degeneration. Surv Ophthalmol. 2014;59(1):1–18. doi:10.1016/j.survophthal.2013.03.009.
  • Sacconi R, Corbelli E, Querques L, Bandello F, Querques G. A review of current and future management of geographic atrophy. Ophthalmol Ther. 2017;6(1):69–77. doi:10.1007/s40123-017-0086-6.
  • Clemons TE, Milton RC, Klein R, Seddon JM, Ferris FL 3rd. Age-related eye disease study research group. risk factors for the incidence of advanced age-related macular degeneration in the age-related eye disease study (AREDS) AREDS report No. 19. Ophthalmol. 2005;112:533–539.
  • Ferris FL, Davis MD, Clemons TE, et al. Asimplified severity scale for age-related macular degeneration. Arch Ophthalmol. 2005; 123(11): 1570–1574. AREDS Report No. 18
  • Seddon JM, Silver RE, Kwong M, Rosner B. Risk prediction for progression of macular degeneration: 10 common and rare genetic variants, demographic, environmental, and macular covariates. Invest Ophthalmol Vis Sci. 2015;56(4):2192–2202. doi:10.1167/iovs.14-15841.
  • Perlee LT, Bansal AT, Gehrs K, et al. Inclusion of genotype with fundus phenotype improves accuracy of predicting choroidal neovascularization and geographic atrophy. Ophthalmol. 2013;120(9):1880–1892. doi:10.1016/j.ophtha.2013.02.007.
  • Shin KU, Song SJ, Bae JH, Lee MY. Risk prediction model for progression of age-related macular degeneration. Ophthalmic Res. 2017;57(1):32–36. doi:10.1159/000449168.
  • Lovie-Kitchin J, Feigl B. Assessment of age-related maculopathy using subjective vision tests. Clin Exp Optom. 2005;88(5):292–303. doi:10.1111/j.1444-0938.2005.tb06713.x.
  • Hogg RE, Chakravarthy U. Visual function and dysfunction in early and late age-related maculopathy. Prog Retin Eye Res. 2006;25(3):249–276. doi:10.1016/j.preteyeres.2005.11.002.
  • Brown B, Lovie-Kitchin J. Contrast sensitivity in central and paracentral retina in age related maculopathy. Clin Exp Optom. 1987;70(5):145–148. doi:10.1111/j.1444-0938.1987.tb04234.x.
  • Kleiner RC, Enger C, Alexander MF, Fine SL. Contrast sensitivity in age-related macular degeneration. Arch Ophthalmol. 1988;106(1):55–57. doi:10.1001/archopht.1988.01060130061028.
  • Stangos N, Voutas S, Topouzis F, Karampatakis V. Contrast sensitivity evaluation in eyes predisposed to age-related macular degeneration and presenting normal visual acuity. Ophthalmologica. 1995;209(4):194–198. doi:10.1159/000310612.
  • Collins MJ. Pre-age related maculopathy and the desaturated D-15 colour vision test. Clin Exp Optom. 1986;69(6):223–227. doi:10.1111/j.1444-0938.1986.tb04596.x.
  • Applegate RA, Adams AJ, Cavender JC, Zisman F. Early color vision changes in age-related maculopathy. Appl Opt. 1987;26(8):1458–1462. doi:10.1364/AO.26.001458.
  • Arden GB, Wolf JE. Colour vision testing as an aid to diagnosis and management of age related maculopathy. Br J Ophthalmol. 2004;88(9):1180–1185. doi:10.1136/bjo.2003.033480.
  • Feigl B, Brown B, Lovie-Kitchin J, Swann P. Cone-mediated multifocal electroretinogram in early age-related maculopathy and its relationships with subjective macular function tests. Curr Eye Res. 2004;29(4–5):327–336. doi:10.1080/02713680490516198.
  • Dimitrov PN, Robman LD, Varsamidis M, et al. Visual function tests as potential biomarkers in age-related macular degeneration. Invest Ophthalmol Vis Sci. 2011;52(13):9457–9469. doi:10.1167/iovs.10-7043.
  • Dimitrov PN, Robman LD, Varsamidis M, et al. Relationship between clinical macular changes and retinal function in age-related macular degeneration. Invest Ophthalmol Vis Sci. 2012;53(9):5213–5220. doi:10.1167/iovs.11-8958.
  • Mayer MJ, Spiegler SJ, Ward B, Glucs A, Kim CB. Foveal flicker sensitivity discriminates ARM-risk from healthy eyes. Invest Ophthalmol Vis Sci. 1992;33:3143–3149.
  • Collins MJ, Brown B. Glare recovery and it’s relation to other clinical findings in age related maculopathy. Clin Vis Sci. 1989;4(2):155–163.
  • Midena E, Degli Angeli C, Blarzino MC, Valenti M, Segato T. Macular function impairment in eyes with early age-related macular degeneration. Invest Ophthalmol Vis Sci. 1997;38:469–477.
  • Owsley C, Jackson GR, White M, Feist R, Edwards D. Delays in rod-mediated dark adaptation in early age-related maculopathy. Ophthalmol. 2001;108(7):1196–1202. doi:10.1016/S0161-6420(01)00580-2.
  • Owsley C, Huisingh C, Clark ME, Jackson GR, McGwin G Jr. Comparison of visual function in older eyes in the earliest stages of age-related macular degeneration to those in normal macular health. Curr Eye Res. 2016;41(2):266–272. doi:10.3109/02713683.2015.1011282.
  • Wang YZ, Wilson E, Locke KG, Edwards AO. Shape discrimination in age-related macular degeneration. Invest Ophthalmol Vis Sci. 2002;43:2055–2062.
  • Bedell HE, Tong J, Woo SY, House JR, Nguyen T. Orientation discrimination with macular changes associated with early AMD. Optom Vis Sci. 2009;86(5):485–491. doi:10.1097/OPX.0b013e31819fa6e2.
  • Brown B, Zadnik K, Bailey IL, Colenbrander A. Effect of luminance, contrast, and eccentricity on visual acuity in senile macular degeneration. Am J Optom Physiol Opt. 1984;61(4):265–270. doi:10.1097/00006324-198404000-00006.
  • Maynard ML, Zele AJ, Feigl B. Mesopic Pelli-Robson contrast sensitivity and MP-1 microperimetry in healthy ageing and age-related macular degeneration. Acta Ophthalmol. 2016;94(8):e772–8. doi:10.1111/aos.13112.
  • Mayer MJ, Spiegler SJ, Ward B, Glucs A, Kim CB. Preliminary evaluation of flicker sensitivity as a predictive test for exudative age-related maculopathy. Invest Ophthalmol Vis Sci. 1992;33:3150–3155.
  • Sunness JS, Massof RW, Johnson MA, Bressler NM, Bressler SB, Fine SL. Diminished foveal sensitivity may predict the development of advanced age-related macular degeneration. Ophthalmol. 1989;96(3):375–381. doi:10.1016/S0161-6420(89)32883-1.
  • Eisner A, Klein ML, Zilis JD, Watkins MD. Visual function and the subsequent development of exudative age-related macular degeneration. Invest Ophthalmol Vis Sci. 1992;33:3091–3102.
  • Sandberg MA, Weiner A, Miller S, Gaudio AR. High-risk characteristics of fellow eyes of patients with unilateral neovascular age-related macular degeneration. Ophthalmol. 1998;105(3):441–447. doi:10.1016/S0161-6420(98)93025-1.
  • Luu CD, Dimitrov PN, Robman L, et al. Role of flicker perimetry in predicting onset of late-stage age-related macular degeneration. Arch Ophthalmol. 2012;130(6):690–699. doi:10.1001/archophthalmol.2012.277.
  • Haegerstrom-Portnoy G, Schneck ME, Brabyn JA. Seeing into old age: vision function beyond acuity. Optom Vis Sci. 1999;76(3):141–158. doi:10.1097/00006324-199903000-00014.
  • Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12(3):189–198. doi:10.1016/0022-3956(75)90026-6.
  • Ferris FL 3rd, Wilkinson CP, Bird A, et al. Clinical classification of age-related macular degeneration. Ophthalmol. 2013;120(4):844–851. doi:10.1016/j.ophtha.2012.10.036.
  • Haegerstrom-Portnoy G, Brabyn J, Schneck ME, Jampolsky A. The SKILL card. An acuity test of reduced luminance and contrast. Smith-Kettlewell Institute Low Luminance. Invest Ophthalmol Vis Sci. 1997;38:207–218.
  • Arditi A. Improving the design of the letter contrast sensitivity test. Invest Ophthalmol Vis Sci. 2005;46(6):2225–2229. doi:10.1167/iovs.04-1198.
  • Wang YZ, He Y-G, Mitzel G, Zhang S, Bartlett M. Handheld shape discrimination hyperacuity test on a mobile device for remote monitoring of visual function in maculopathy. Invest Ophthalmol Vis Sci. 2013;54(8):5497–5505. doi:10.1167/iovs.13-12037.
  • Adams AJ, Rodic R. Use of desaturated and saturated versions of the D-15 test in glaucoma and glaucoma suspect patients. In: Verriest G, ed.. Colour Vision Deficiencies VI: Proceedings of the Sixth Symposium of the International Research Group on Colour Vision Deficiencies Held at the Klinikum Der Freien Universität; (West) Berlin-Steglitz. 17-19 September 1981. The Hague: W. Junk Publishers; 1982:419–424.
  • Adams AJ, Haegerstrom-Portnoy G. Color deficiency. In: Amos JF, ed.. Diagnosis and Management in Vision Care. Boston MA: Butterworths; 1987:671–713.
  • Bowman KJ. Amethod for quantitative scoring of the Farnsworth Panel D-15. Acta Ophthalmol (Copenh). 1982;60(6):907–916. doi:10.1111/j.1755-3768.1982.tb00621.x.
  • Vingrys AJ, King-Smith PE. Aquantitative scoring technique for panel tests of color vision. Invest Ophthalmol Vis Sci. 1988;29:50–63.
  • Trauzettel-Klosinski S, Dietz K. IReST Study Group. Standardized assessment of reading performance: the new international reading speed texts IReST. Invest Ophthalmol Vis Sci. 2012;53(9):5452–5461. doi:10.1167/iovs.11-8284.
  • Whittaker SG, Lovie-Kitchin J. Visual requirements for reading. Optom Vis Sci. 1993;70(1):54–65. doi:10.1097/00006324-199301000-00010.
  • Cheong AC, Lovie-Kitchin JE, Bowers AR. Determining magnification for reading with low vision. Clin Exp Optom. 2002;85(4):229–237. doi:10.1111/j.1444-0938.2002.tb03042.x.
  • Liang K-Y, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrika. 1986;73(1):13–22. doi:10.1093/biomet/73.1.13.
  • Hardin JW, Hilbe JM. Generalized Estimating Equations. 2nd. Boca Raton, FL: CRC Press, Taylor & Francis Group, 2013.
  • Murdoch IE, Morris SS, Cousens SN. People and eyes: statistical approaches in ophthalmology. Br J Ophthalmol. 1998;82(8):971–973. doi:10.1136/bjo.82.8.971.
  • Fan Q, Teo Y-Y, Saw S-M. Application of advanced statistics in ophthalmology. Invest Ophthalmol Vis Sci. 2011;52(9):6059–6065. doi:10.1167/iovs.10-7108.
  • Touloumis A, Agresti A, Kateri M. R Package multgee: a Generalized Estimating Equations Solver for Multinomial Responses. Biometrics. 2013;69(3):633–640. doi:10.1111/biom.12054.
  • Schneck ME, Haegerstrom-Portnoy G, Lott LA, Brabyn JA. Comparisons of panel D-15 tests in a large older population. Optom Vis Sci. 2014;91(3):284–290. doi:10.1097/OPX.0000000000000152.
  • Allison P. When can you safely ignore multicollinearity? (September, 2012). Accessed 15 June 20 https://statisticalhorizons.com/multicollinearity
  • Schneck ME, Lott LA, Haegerstrom-Portnoy G, et al. Visual function in eyes with intermediate age-related macular degeneration with and without retinal pigment abnormalities. Optom Vis Sci. Revised and resubmitted, 29 May 20.
  • Davis MD, Gangnon RE, Lee LY, et al. The age-related eye disease study severity scale for age-related macular degeneration: AREDS report no. 17. Arch Ophthalmol. 2005;123(11):1484–1498.
  • Collins M, Brown B. Glare recovery and age-related maculopathy. Clin Vis Sci. 1989;4(2):145–153.
  • Haegerstrom-Portnoy G, Brown B. Two-color increment thresholds in early age related maculopathy. Clin Vis Sci. 1989;4(2):165–172.
  • Wilkinson F, Wilson HR, Habak C. Detection and recognition of radial frequency patterns Vision Res. 1998;38(22):3555–3568. doi:10.1016/S0042-6989(98)00039-X.
  • Hess RF, Wang YZ, Dakin SJ. Are judgments of circularity local or global? Vision Res. 1999;39(26):4354–4360. doi:10.1016/S0042-6989(99)00153-4.
  • Jeffrey BG, Wang YZ, Birch EE. Circular contour frequency in shape discrimination. Vision Res. 2002;42(25):2773–2779. doi:10.1016/S0042-6989(02)00332-2.
  • Loffler G, Wilson HR, Wilkinson F. Local and global contributions to shape discrimination. Vision Res. 2003;43(5):519–530. doi:10.1016/S0042-6989(02)00686-7.
  • Ku JY, Milling AF, Pitrelli VN, Knox PC. Performance, usability and comparison of two versions of a new macular vision test: the handheld radial shape discrimination test. PeerJ. 2016;4:e2650. doi:10.7717/peerj.2650.